Furthermore, recent research demonstrated that dual inhibition of BCL-XL and MCL-1 synergistically reduces viability and induces death in neuroblastoma cell lines displaying treatment resistance to individual BCL-2, BCL-XL, or MCL-1 inhibitors [99]. The gene discussed is BCL2L1; the disease is neuroblastoma.